Engaging European society at the forefront of cancer research and care: How discussions at the 5
Mission on Cancer
cancer prevention
cancer research
policy
Journal
Molecular oncology
ISSN: 1878-0261
Titre abrégé: Mol Oncol
Pays: United States
ID NLM: 101308230
Informations de publication
Date de publication:
06 2023
06 2023
Historique:
revised:
26
03
2023
received:
17
03
2023
accepted:
17
03
2023
medline:
12
6
2023
pubmed:
21
3
2023
entrez:
20
3
2023
Statut:
ppublish
Résumé
European cancer research stakeholders met in October 2022 in Heidelberg, Germany, at the 5
Identifiants
pubmed: 36938773
doi: 10.1002/1878-0261.13423
pmc: PMC10257409
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
925-945Subventions
Organisme : World Health Organization
ID : 001
Pays : International
Informations de copyright
© 2023 The Authors. Molecular Oncology published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies.
Références
JCO Clin Cancer Inform. 2022 Mar;6:e2100149
pubmed: 35483002
Mol Oncol. 2022 Sep;16(18):3220-3237
pubmed: 35503718
Mol Oncol. 2017 Dec;11(12):1661-1672
pubmed: 29024497
Mol Oncol. 2020 Aug;14(8):1589-1615
pubmed: 32749074
Eur J Cancer. 2020 Apr;129:41-49
pubmed: 32120274
Nature. 2019 Oct;574(7776):127-131
pubmed: 31570881
Lancet Oncol. 2023 Jan;24(1):5-6
pubmed: 36400099
Mol Oncol. 2019 Mar;13(3):549-557
pubmed: 30698321
Mol Oncol. 2019 Mar;13(3):497-501
pubmed: 30811864
Int J Cancer. 2022 Feb 15;150(4):580-593
pubmed: 34569617
Mol Oncol. 2021 Oct;15(10):2507-2543
pubmed: 34515408
Lancet Oncol. 2023 Jan;24(1):8-9
pubmed: 36400105
Diagnostics (Basel). 2021 Nov 15;11(11):
pubmed: 34829458
BMJ. 2022 Feb 2;376:o282
pubmed: 35115384
BMJ Open. 2020 Nov 17;10(11):e043828
pubmed: 33203640
Nat Cancer. 2022 Feb;3(2):251-261
pubmed: 35221333
Cancer Manag Res. 2022 Oct 31;14:3105-3118
pubmed: 36340999
Clin Pharmacol Ther. 2019 Apr;105(4):867-877
pubmed: 30636285
Ann Oncol. 2018 Sep 1;29(9):1895-1902
pubmed: 30137196
Mol Oncol. 2019 Mar;13(3):567-578
pubmed: 30582778
Cancer Causes Control. 2014 May;25(5):615-24
pubmed: 24658968
Diagnostics (Basel). 2022 Mar 30;12(4):
pubmed: 35453900
N Engl J Med. 2017 May 25;376(21):2006-2009
pubmed: 28538124
Mol Oncol. 2019 Mar;13(3):528-534
pubmed: 30667152
Lancet Oncol. 2018 Aug;19(8):1014-1015
pubmed: 30102210
Mol Oncol. 2021 Dec;15(12):3225-3241
pubmed: 34003576
Eur J Cancer. 2021 Nov;157:308-347
pubmed: 34560371
BMJ. 2022 Sep 21;378:o2197
pubmed: 36130783
Mol Oncol. 2018 Nov;12(11):1829-1837
pubmed: 30241109
Lancet Oncol. 2023 Jan;24(1):e11-e56
pubmed: 36400101
Lancet Oncol. 2023 Jan;24(1):6-8
pubmed: 36400103
Mol Oncol. 2009 Feb;3(1):5-8
pubmed: 19383361
Nat Genet. 2020 Apr;52(4):448-457
pubmed: 32246132
Front Pharmacol. 2021 Aug 10;12:699466
pubmed: 34456724
Ann Oncol. 2021 Jul;32(7):926-932
pubmed: 33862157